Srs Capital Advisors, Inc. Agios Pharmaceuticals, Inc. Transaction History
Srs Capital Advisors, Inc.
- $1.07 Billion
- Q3 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 116 shares of AGIO stock, worth $6,311. This represents 0.0% of its overall portfolio holdings.
Number of Shares
116
Previous 122
4.92%
Holding current value
$6,311
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AGIO
# of Institutions
233Shares Held
58.1MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$308 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$302 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$264 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$203 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$154 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.98B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...